IL144721A0 - Method for the prevention or reduction of cardiovascular events associated with coronary intervention - Google Patents

Method for the prevention or reduction of cardiovascular events associated with coronary intervention

Info

Publication number
IL144721A0
IL144721A0 IL14472100A IL14472100A IL144721A0 IL 144721 A0 IL144721 A0 IL 144721A0 IL 14472100 A IL14472100 A IL 14472100A IL 14472100 A IL14472100 A IL 14472100A IL 144721 A0 IL144721 A0 IL 144721A0
Authority
IL
Israel
Prior art keywords
prevention
reduction
events associated
cardiovascular events
coronary intervention
Prior art date
Application number
IL14472100A
Other languages
English (en)
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of IL144721A0 publication Critical patent/IL144721A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14472100A 1999-02-03 2000-02-02 Method for the prevention or reduction of cardiovascular events associated with coronary intervention IL144721A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11846299P 1999-02-03 1999-02-03
PCT/US2000/002622 WO2000045811A1 (en) 1999-02-03 2000-02-02 Method for the prevention or reduction of cariovascular events associated with coronary intervention

Publications (1)

Publication Number Publication Date
IL144721A0 true IL144721A0 (en) 2002-06-30

Family

ID=22378750

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14472100A IL144721A0 (en) 1999-02-03 2000-02-02 Method for the prevention or reduction of cardiovascular events associated with coronary intervention

Country Status (17)

Country Link
EP (1) EP1171116A4 (xx)
JP (1) JP2002536327A (xx)
KR (1) KR20010101934A (xx)
CN (1) CN1345237A (xx)
AU (1) AU2636600A (xx)
BR (1) BR0007921A (xx)
CA (1) CA2361581A1 (xx)
CO (1) CO5150206A1 (xx)
HK (1) HK1045104A1 (xx)
HU (1) HUP0200129A3 (xx)
IL (1) IL144721A0 (xx)
MX (1) MXPA01007835A (xx)
NO (1) NO20013788L (xx)
PL (1) PL351397A1 (xx)
TR (1) TR200102245T2 (xx)
WO (1) WO2000045811A1 (xx)
ZA (1) ZA200106353B (xx)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
KR19990044478A (ko) * 1995-09-07 1999-06-25 간자와 무츠와 2-아실아미노벤즈아미드 유도체 및 혈관내막세포 과잉증식에 기인하는 질환의 예방 및 치료제
US6019104A (en) * 1996-12-30 2000-02-01 Kissei Pharmaceutical Co., Ltd. Method for the treatment or prevention of restenosis associated with coronary intervention

Also Published As

Publication number Publication date
HUP0200129A3 (en) 2003-06-30
ZA200106353B (en) 2002-08-02
CO5150206A1 (es) 2002-04-29
BR0007921A (pt) 2002-09-10
CA2361581A1 (en) 2000-08-10
EP1171116A4 (en) 2004-11-17
JP2002536327A (ja) 2002-10-29
AU2636600A (en) 2000-08-25
MXPA01007835A (es) 2002-04-24
CN1345237A (zh) 2002-04-17
EP1171116A1 (en) 2002-01-16
PL351397A1 (en) 2003-04-07
NO20013788D0 (no) 2001-08-02
HUP0200129A2 (hu) 2002-05-29
TR200102245T2 (tr) 2002-05-21
WO2000045811A1 (en) 2000-08-10
HK1045104A1 (zh) 2002-11-15
NO20013788L (no) 2001-09-28
KR20010101934A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
GB2352377B (en) Noise suppression method
GB2354240B (en) Method for the preparation of citalopram
HK1040266B (zh) 鈦合金及其製備方法
GB2354239B (en) Method for the preparation of citalopram
HK1048122B (zh) 製備西酞普蘭的方法
PL347492A1 (en) New esters derived from substituted phenyl-cyclohexyl compounds
IL148803A0 (en) Novel composition and method for stabilizing the same
AU5294100A (en) Method and compositions for treating the inflammatory response
GB2360281B (en) Method for the preparation of citalopram
PL351644A1 (en) Method and arrangement for the manufacture of lignocellulose-containing boards
HK1043129A1 (en) Method for the preparation of citalopram
IL144719A0 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
AU2001275414A1 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
IL144721A0 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
AU2001243248A1 (en) Method for the prevention or reduction of vascular access dysfunction
SI1216038T1 (sl) Ramipril za preprecevanje kardiovaskularnih dogodkov
TW437347U (en) Shelving for suspension from rafters or the like
AU144457S (en) Pit component
ZA200007580B (en) Materials and methods for prevention or reduction of the severity of heartwater.
PL108457U1 (en) Metal furniture framework
TW376703U (en) Structure of the shelves of combination type
TW417610U (en) Structure improvement of the steel rim
AU145113S (en) Flange
TW371938U (en) Improvement of the basket